the importance of using mrd to guide treatment decisions in all
Published 11 months ago • 116 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
0:58
management strategies for acute and chronic gvhd following allosct
-
2:04
state-of-the-art treatment for hr-mds
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:30
point of care testing
-
3:19
analysis of long-term survival in a large apl patient cohort: a harmony alliance study
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
2:16
current and future treatment approaches for hr-mds
-
1:18
the epidemiology and treatment of chronic gvhd post-allosct
-
3:50
advances in the prevention and treatment of gvhd
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
1:30
evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
1:36
chemotherapy and allohsct in the treatment of all
-
2:43
the management of advanced phase mpns
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
0:58
current research and next steps to improve the understanding and management of icaht